tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market

Neuphoria Therapeutics (NEUP) Financial Statements

Compare
240 Followers

Neuphoria Therapeutics Financial Overview

Neuphoria Therapeutics's market cap is currently $13.50M. The company's EPS TTM is $-0.062; its P/E ratio is ―; Neuphoria Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 0.00AU$ 181.36KAU$ 0.00AU$ 32.06K
Gross ProfitAU$ 0.00AU$ 181.36KAU$ 0.00AU$ 32.06K
Operating IncomeAU$ -17.89M---
EBITDAAU$ -17.13M---
Net IncomeAU$ -15.49M---
Balance Sheet
Cash & Short-Term InvestmentsAU$ 12.61MAU$ 23.09MAU$ 21.41MAU$ 3.15M
Total AssetsAU$ 27.65MAU$ 44.93MAU$ 40.77MAU$ 23.68M
Total DebtAU$ 272.74KAU$ 477.15KAU$ 652.04KAU$ 8.41M
Net DebtAU$ -12.34M--AU$ 5.26M
Total LiabilitiesAU$ 10.16MAU$ 5.78MAU$ 5.01MAU$ 14.97M
Stockholders' EquityAU$ 17.49MAU$ 39.15MAU$ 35.76MAU$ 8.71M
Cash Flow
Free Cash FlowAU$ -14.68M---
Operating Cash FlowAU$ -14.68M---
Investing Cash FlowAU$ 0.00AU$ 427.68K--
Financing Cash FlowAU$ 15.11MAU$ 18.57MAU$ 23.71M-
Currency in AUD

Neuphoria Therapeutics Earnings and Revenue History

Neuphoria Therapeutics Debt to Assets

Neuphoria Therapeutics Cash Flow

Neuphoria Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis